Stryker Buys Ortho Oncology Specialist Stanmore Implants
This article was originally published in The Gray Sheet
Executive Summary
The approximately $52 million deal increases Stryker's offerings for limb-salvage procedures for cancer patients.
You may also be interested in...
Will Stryker’s MAKO Purchase Bring Disruption To The Ortho Industry?
Stryker’s adoption of MAKO’s RIO (Robotic-arm Interactive Orthopedic) system could give the global medical supplier a competitive edge over other orthopedic implant makers if the company can win converts to robotic surgery by leveraging its own experience in selling capital equipment.
ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach
Vision Healthcare’s Sensilab pulled Facebook advertisements for its weight loss supplements after UK regulator the Advertising Standards Authority launched an investigation into whether the marketing, which featured slim models, was "irresponsible."
Obituary: Wolfgang Ollig, Stada CFO
The death has been announced of Stada’s chief financial officer, Wolfgang Ollig.